What is GLP (Good Laboratory Practice)?
Read this blog to understand GLP (Good Laboratory Practice) and associated QA audits, and proper…
CertaraMarch 18, 2026
Certara Welcomes Arjun Bedi to its Board of Directors
Certara has appointed Arjun Bedi to its Board of Directors. His life sciences expertise will…
CertaraMarch 12, 2026
Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026
Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…
CertaraMarch 11, 2026
Certara Announces 2026 Certainty Event
Certainty 2026: Explore AI-driven drug development and technological innovation at the leading biosimulation event for…
CertaraMarch 9, 2026
Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer
This study used model-based meta-analysis (MBMA) to assess how well objective response rate (ORR) predicts…
Danielle PillsburyMarch 4, 2026
ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success
Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…
CertaraMarch 3, 2026
